James E Dentzer
CIK 1400977 · View on SEC EDGAR ↗
First SEC filing: Oct. 3, 2022 · Latest: Oct. 3, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2022 | CRIS | S 10b5-1 | 3,094 | $3.07 | $9,499 | 64,877 Direct | -4.55% | Disposed | -99.9% (price as of 2026-08-19) |
| Jan. 27, 2022 | CRIS | S | 2,406 | $3.18 | $7,651 | 67,971 Direct | -3.42% | Disposed | -99.9% (price as of 2026-08-19) |
| Jan. 26, 2021 | CRIS | S 10b5-1 | 3,094 | $10.59 | $32,765 | 67,268 Direct | -4.40% | Disposed | -100.0% (price as of 2026-08-19) |
| Jan. 25, 2021 | CRIS | S | 2,283 | $10.96 | $25,022 | 70,362 Direct | -3.14% | Disposed | -100.0% (price as of 2026-08-19) |
| Jan. 24, 2020 | CRIS | S 10b5-1 | 3,094 | $1.64 | $5,074 | 42,158 Direct | -6.84% | Disposed | -99.7% (price as of 2026-08-19) |
| Jan. 23, 2020 | CRIS | S 10b5-1 | 3,658 | $1.69 | $6,182 | 45,252 Direct | -7.48% | Disposed | -99.7% (price as of 2026-08-19) |
| Jan. 24, 2019 | CRIS | S 10b5-1 | 3,094 | $1.16 | $3,589 | 41,639 Direct | -6.92% | Disposed | -99.6% (price as of 2026-08-19) |
| Jan. 23, 2019 | CRIS | S 10b5-1 | 2,397 | $1.09 | $2,613 | 44,733 Direct | -5.09% | Disposed | -99.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 7, 2026 | CRIS | Employee stock option (right to buy) | Common Stock (110,090) | $5.29 | July 6, 2036 | 110,090 | Acquired |
| March 20, 2026 | CRIS | Series B Convertible Preferred Stock | Common Stock (133,333) | — | — | 100 | Disposed |
| March 17, 2026 | CRIS | Series C Warrant (right to buy) | Common Stock (133,333) | $0.75 | July 8, 2027 | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series B Warrant (right to buy) | Common Stock (133,333) | — | — | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series A Warrant (right to buy) | Common Stock (133,333) | $0.75 | Jan. 8, 2031 | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series B Convertible Preferred Stock | Common Stock (100) | — | — | 100 | Acquired |
| May 20, 2025 | CRIS | Employee stock option (right to buy) | Common Stock (360,000) | $3.13 | Jan. 27, 2035 | 360,000 | Acquired |
| Jan. 28, 2025 | CRIS | Employee stock option (right to buy) | Common Stock (40,000) | $3.13 | Jan. 27, 2035 | 40,000 | Acquired |
| May 21, 2024 | CRIS | Employee stock option (right to buy) | Common Stock (100,000) | $11.62 | Jan. 18, 2034 | 100,000 | Acquired |
| Jan. 20, 2023 | CRIS | Employee stock option (right to buy) | Common Stock (1,000,000) | $0.70 | Jan. 19, 2033 | 1,000,000 | Acquired |
| Sept. 30, 2022 | IMNN | Option (right to buy) | Common Stock (2,667) | $1.68 | Sept. 30, 2032 | 2,667 | Acquired |
| Jan. 29, 2022 | CRIS | Employee stock option (right to buy) | Common stock (825,000) | $3.09 | Jan. 28, 2032 | 825,000 | Acquired |
| Jan. 28, 2021 | CRIS | Employee stock option (right to buy) | Common stock (330,000) | $9.14 | Jan. 27, 2031 | 330,000 | Acquired |
| March 2, 2020 | CRIS | Employee stock option (right to buy) | Common stock (750,000) | $1.26 | March 1, 2030 | 750,000 | Acquired |
| May 23, 2019 | CRIS | Employee stock option (right to buy) | Common Stock (1,115,871) | $1.16 | Jan. 20, 2029 | 1,115,871 | Acquired |
| Sept. 26, 2018 | CRIS | Employee stock option (right to buy) | Common stock (750,000) | $1.62 | Sept. 25, 2028 | 750,000 | Acquired |
| May 15, 2018 | CRIS | Employee stock option (right to buy) | Common stock (825,000) | $0.69 | Jan. 21, 2028 | 825,000 | Acquired |
| March 29, 2016 | CRIS | Employee stock option (right to buy) | Common stock (1,700,000) | $1.51 | March 29, 2026 | 1,700,000 | Acquired |
| Feb. 14, 2014 | CRIS | Employee stock option (right to buy) | Common stock (650,000) | $2.63 | Feb. 13, 2027 | 650,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 3, 2022 | IMNN | Common Stock | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $590,212 | — | — | — | $378,780 | — | $21,039 | $3,390,187 |
| 2020 | $544,900 | — | — | — | $476,685 | — | $14,189 | $1,672,849 |
| 2018 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.